# Indole-3-Carbinol in Preventing Cancer in Healthy Participants

> **NCT00100958** · PHASE1 · COMPLETED · sponsor: **University of Kansas**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** indole-3-carbinol

## Key facts

- **NCT ID:** NCT00100958
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100958, "Indole-3-Carbinol in Preventing Cancer in Healthy Participants". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00100958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*